Human sTNF-R (60kDa) Instant ELISA

Also known as: Tumor necrosis factor receptor 1, TNF-R1, CD120a

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# BMS203INST*

Cat. No. Size
BMS203INST 128 tests
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Human sTNF-R (60kDa) Instant ELISA.

Click on image to view more information.

  • Data for Human sTNF-R (60kDa) Instant ELISA.
Description

Description: The human sTNF-R (60kDa) Instant ELISA is an enzyme-linked immunosorbent assay for the quantitative detection of soluble human 60 kDa Tumor Necrosis Factor-Receptor. The human sTNF-R (60kDa) Instant ELISA is for research use only. Not for diagnostic or therapeutic procedures.

TNF-receptors have been demonstrated on a wide variety of human somatic cells including fibroblasts, endothelial cells, adipocytes, liver membranes, granulocytes and several tumor cell lines. Based on gel filtration experiments the receptor appears to be a complex of different proteins with a molecular weight of 350 kDa. In a variety of cell lines two different types of TNF receptors with 75-80 and 55-60 kDa respectively have been identified. The cDNAs encoding the two different TNF receptors have been cloned. The exact mechanism of signal transduction after binding of TNF to the receptor is still unclear. The extracellular fragment of the 60 kDa TNF receptor, with a molecular mass of about 30 kDa was purified, partially sequenced, and the respective cDNA was cloned. This TNF binding protein is liberated from the intact molecule by proteolytic cleavage and comprises most of the extracellular portion of the receptor, including all three N-glycosylation sites.

The present assay provides a simple, rapid, and highly sensitive method for the determination of soluble TNF-R (60 kDa) levels in body fluids or cell culture supernatants. This assay will help to clarify the possible diagnostic and prognostic value of circulating sTNF-R (60 kDa) in various neoplastic and inflammatory diseases.

Details
Reactivity Human
Sample Volume 10 uL
Suitable Sample Types cell culture supernatant, serum, plasma
Sensitivity 53 pg/mL
Standard Curve Range 0.078 - 5.0 ng/mL
Components Aluminium pouch(es) with a Microwell Plate coated with Monoclonal Antibody (murine) to human sTNF-R (60 kDa) and HRP-Conjugate (anti-sTNF-R (60 kDa) monoclonal (murine) antibody), lyophilized
Aluminium pouch(es) with a human sTNF-R (60kDa) Standard curve (coloured)
Wash Buffer Concentrate 20x (phosphate-buffered saline with 1% Tween 20)
Substrate Solution (tetramethyl-benzidine)
Assay Buffer Concentrate 20x (Use when an external predilution of the samples is needed)
Stop Solution (1M Phosphoric acid)
Adhesive Plate Covers
Reported Applications ELISA
Documentation
TDS Link Download TDS
Related Products
Cat. No. Name Excite Emit Application Reg.
85-86081 NFkB p65 (Total) InstantOne™ ELISA ELISA RUO
BMS211* Human sTNF-R (80kDa) Platinum ELISA ELISA RUO
BMS240INST* Human sCD30 Instant ELISA ELISA RUO
BMS244/3* Human Bcl-2 Platinum ELISA ELISA RUO
BMS810FFRTU* Human Th1/Th2 11plex Ready-to-Use FlowCytomix Multiplex Multiplex RUO
References

Citations: Mavridis,G.; Souliou,E.; Diza,E.; Symeonidis,G.; Pastore,F.; Vassiliou,A.M.; Karamitsos,D.. Inflammatory cytokines in insulin-treated patients with type 2 diabetes. Nutrition, Metabolism and Cardiovascular Diseases 2008;18:471-476. (Link)

Kato,Akihiko; Odamaki,Mari; Takita,Takako; Maruyama,Yukitaka; Kumagai,Hiromichi; Hishida,Akira. Association between interleukin-6 and carotid atherosclerosis in hemodialysis patients. Kidney Int 2002;61:1143-1152. (Link)

Annique,S.; Dorien,T.; Richel,L.; Gunter,K.; Joris,D.; Crijns Harry,J.; Gert,G.; Frank,S.; Michael,M.; Adriaan,H.. Inflammatory markers in depressed post-myocardial infarction patients. Journal of Psychiatric Research 2005;39:137-144. (Link)

Mantzoros,Christos S.; Moschos,Stergios; Avramopoulos,Iraklis; Kaklamani,Virginia; Liolios,Antonios; Doulgerakis,Dimitrios E.; Griveas,Ioannis; Katsilambros,Nicholas; Flier,Jeffrey S.. Leptin Concentrations in Relation to Body Mass Index and the Tumor Necrosis Factor-{alpha} System in Humans. Journal of Clinical Endocrinology & Metabolism 1997;82:3408-3413. (Link)

Airaghi,Lorena; Lettino,Maddalena; Manfredi,Maria Grazia; Lipton,James Matthew; Catania,Anna. Endogenous cytokine antagonists during myocardial ischemia and thrombolytic therapy. American Heart Journal 1995;130:(Link)

Stojanov,S.; Dejaco,C.; Lohse,P.; Huss,K.; Duftner,C.; Belohradsky,B.H.; Herold,M.; Schirmer,M.. Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment. Annals of the Rheumatic Diseases 2008;67:1292-1298. (Link)

Kato,Akihiko; Odamaki,Mari; Takita,Takako; Furuhashi,Mitsuyoshi; Maruyama,Yukitaka; Hishida,Akira. High blood soluble receptor p80 for tumour necrosis factor-{alpha} is associated with erythropoietin resistance in haemodialysis patients. Nephrology Dialysis Transplantation 2001;16:1838-1844. (Link)

Matsushige,T.; Ichiyama,T.; Anlar,B.; Tohyama,J.; Nomura,K.; Yamashita,Y.; Furukawa,S.. CSF neurofilament and soluble TNF receptor 1 levels in subacute sclerosing panencephalitis. Journal of Neuroimmunology 2008;205:155-159. (Link)

Kuhns,D.B.; Long Priel,D.A.; Gallin,J.I.. Endotoxin and IL-1 hyporesponsiveness in a patient with recurrent bacterial infections. The Journal of Immunology 1997;158:3959-3964. (Link)

Zoppini,Giacomo; Faccini,Giovanni; Muggeo,Michele; Zenari,Luciano; Falezza,Giancarlo; Targher,Giovanni. Elevated Plasma Levels of Soluble Receptors of TNF-{alpha} and Their Association with Smoking and Microvascular Complications in Young Adults with Type 1 Diabetes. Journal of Clinical Endocrinology & Metabolism 2001;86:3805-3808. (Link)

Wang,Lin; Chen,Rong Fu; Liu,Jien Wei; Yu,Hong Ren; Kuo,Ho Chang; Yang,Kuender D.. Implications of Dynamic Changes among Tumor Necrosis Factor-{alpha} (TNF-{alpha}), Membrane TNF Receptor, and Soluble TNF Receptor Levels in Regard to the Severity of Dengue Infection. American Journal of Tropical Medicine and Hygiene 2007;77:297-302. (Link)

PRESTERL,E.L.I.S.; STAUDINGER,T.H.O.M.; PETTERMANN,M.A.R.I.; LASSNIGG,A.N.D.R.; BURGMANN,H.E.I.N.; WINKLER,S.T.E.F.; FRASS,M.I.C.H.; GRANINGER,W.O.L.F.. Cytokine Profile and Correlation to the APACHE III and MPM II Scores in Patients with Sepsis. American Journal of Respiratory and Critical Care Medicine 1997;156:825-832. (Link)

Nishikawa,M.; Matsubara,T.; Yoshitomi,T.; Ichiyama,T.; Hayashi,T.; Furukawa,S.. Abnormalities of brain perfusion in echovirus type 30 meningitis. Journal of the Neurological Sciences 2000;179:122-126. (Link)

Papa,A.; Bino,S.; Velo,E.; Harxhi,A.; Kota,M.; Antoniadis,A.. Cytokine levels in Crimean-Congo hemorrhagic fever. Journal of Clinical Virology 2006;36:272-276. (Link)

Panafidina,T.A.; Popkova,T.V.; Alekberova,Z.S.; Mach,E.S.; Novikova,D.S.; Novikov,A.A.; Alexandrova,E.N.; Nasonov,E.L.. INFLAMMATORY MARCERS IN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS. EULAR Meeting Abstracts 2006;65:355(Link)

Ichiyama,Takashi; Isumi,Hiroshi; Ozawa,Hiroshi; Matsubara,Tomoyo; Morishima,Tsuneo; Furukawa,Susumu. Cerebrospinal fluid and serum levels of cytokines and soluble tumor necrosis factor receptor in influenza virus-associated encephalopathy.. Scandinavian Journal of Infectious Diseases 2003;35:59-61. (Link)

References: Smith,C.A.; Davis,T.; Anderson,D.; Solam,L.; Beckmann,M.P.; Jerzy,R.; Dower,S.K.; Cosman,D.; Goodwin,R.G.. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 1990;248:1019-1023. (Link)

Loetscher,H.; Pan,Y.C.; Lahm,H.W.; Gentz,R.; Brockhaus,M.; Tabuchi,H.; Lesslauer,W.. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 1990;61:351-359. (Link)

Scheurich,P.; Thoma,B.; Ucer,U.; Pfizenmaier,K.. Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses. J.Immunol. 1987;138:1786-1790. (Link)

Schall,T.J.; Lewis,M.; Koller,K.J.; Lee,A.; Rice,G.C.; Wong,G.H.; Gatanaga,T.; Granger,G.A.; Lentz,R.; Raab,H.; .. Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 1990;61:361-370. (Link)

Aggarwal,B.B.; Eessalu,T.E.; Hass,P.E.. Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon. Nature 1985;318:665-667. (Link)

Brockhaus,M.; Schoenfeld,H.J.; Schlaeger,E.J.; Hunziker,W.; Lesslauer,W.; Loetscher,H.. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc.Natl.Acad.Sci.U.S.A 1990;87:3127-3131. (Link)

Adolf,G.R.; Apfler,I.. A monoclonal antibody-based enzyme immunoassay for quantitation of human tumor necrosis factor binding protein I, a soluble fragment of the 60 kDa TNF receptor, in biological fluids. J.Immunol.Methods 1991;143:127-136. (Link)

Creasey,A.A.; Yamamoto,R.; Vitt,C.R.. A high molecular weight component of the human tumor necrosis factor receptor is associated with cytotoxicity. Proc.Natl.Acad.Sci.U.S.A 1987;84:3293-3297. (Link)

Tsujimoto,M.; Yip,Y.K.; Vilcek,J.. Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells. Proc.Natl.Acad.Sci.U.S.A 1985;82:7626-7630. (Link)

Kull,F.C.,Jr.; Jacobs,S.; Cuatrecasas,P.. Cellular receptor for 125I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity. Proc.Natl.Acad.Sci.U.S.A 1985;82:5756-5760. (Link)

Rubin,B.Y.; Anderson,S.L.; Sullivan,S.A.; Williamson,B.D.; Carswell,E.A.; Old,L.J.. High affinity binding of 125I-labeled human tumor necrosis factor (LuKII) to specific cell surface receptors. J.Exp.Med. 1985;162:1099-1104. (Link)

Paul,N.L.; Ruddle,N.H.. Lymphotoxin. Annu.Rev.Immunol. 1988;6:407-438. (Link)

Beutler,B.; Mahoney,J.; Le,Trang N.; Pekala,P.; Cerami,A.. Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells. J.Exp.Med. 1985;161:984-995. (Link)

Baglioni,C.; McCandless,S.; Tavernier,J.; Fiers,W.. Binding of human tumor necrosis factor to high affinity receptors on HeLa and lymphoblastoid cells sensitive to growth inhibition. J.Biol.Chem. 1985;260:13395-13397. (Link)

Scheurich,P.; Ucer,U.; Kronke,M.; Pfizenmaier,K.. Quantification and characterization of high-affinity membrane receptors for tumor necrosis factor on human leukemic cell lines. Int.J.Cancer 1986;38:127-133. (Link)

Olsson,I.; Lantz,M.; Nilsson,E.; Peetre,C.; Thysell,H.; Grubb,A.; Adolf,G.. Isolation and characterization of a tumor necrosis factor binding protein from urine. Eur.J.Haematol. 1989;42:270-275. (Link)

Munker,R.; DiPersio,J.; Koeffler,H.P.. Tumor necrosis factor: receptors on hematopoietic cells. Blood 1987;70:1730-1734. (Link)

Himmler,A.; Maurer-Fogy,I.; Kronke,M.; Scheurich,P.; Pfizenmaier,K.; Lantz,M.; Olsson,I.; Hauptmann,R.; Stratowa,C.; Adolf,G.R.. Molecular cloning and expression of human and rat tumor necrosis factor receptor chain (p60) and its soluble derivative, tumor necrosis factor-binding protein. DNA Cell Biol. 1990;9:705-715. (Link)

Thoma,B.; Grell,M.; Pfizenmaier,K.; Scheurich,P.. Identification of a 60-kD tumor necrosis factor (TNF) receptor as the major signal transducing component in TNF responses. J.Exp.Med. 1990;172:1019-1023. (Link)

Hohmann,H.P.; Remy,R.; Brockhaus,M.; van Loon,A.P.. Two different cell types have different major receptors for human tumor necrosis factor (TNF alpha). J.Biol.Chem. 1989;264:14927-14934. (Link)